IRIS
VITALE, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.408
EU - Europa 7.823
AS - Asia 4.616
SA - Sud America 837
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 16
Totale 30.839
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.270
RU - Federazione Russa 2.458
CN - Cina 1.796
UA - Ucraina 1.531
SG - Singapore 1.199
VN - Vietnam 1.093
IT - Italia 770
GB - Regno Unito 756
SE - Svezia 674
BR - Brasile 657
DE - Germania 643
FR - Francia 523
FI - Finlandia 150
HK - Hong Kong 128
NL - Olanda 81
AR - Argentina 63
IN - India 59
PL - Polonia 52
CA - Canada 50
BD - Bangladesh 49
MX - Messico 46
JP - Giappone 44
IQ - Iraq 42
EU - Europa 39
ZA - Sudafrica 31
IE - Irlanda 30
EC - Ecuador 28
ID - Indonesia 25
PK - Pakistan 24
BE - Belgio 22
ES - Italia 22
SA - Arabia Saudita 19
AT - Austria 18
CL - Cile 18
MA - Marocco 18
TR - Turchia 18
VE - Venezuela 18
CO - Colombia 17
MY - Malesia 16
PY - Paraguay 16
LV - Lettonia 15
AU - Australia 12
AZ - Azerbaigian 12
TN - Tunisia 12
CR - Costa Rica 11
UZ - Uzbekistan 11
KE - Kenya 10
BO - Bolivia 8
BG - Bulgaria 7
ET - Etiopia 7
GR - Grecia 7
JO - Giordania 7
KR - Corea 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
HN - Honduras 6
JM - Giamaica 6
KZ - Kazakistan 6
LU - Lussemburgo 6
NP - Nepal 6
PH - Filippine 6
PT - Portogallo 6
CH - Svizzera 5
DK - Danimarca 5
IR - Iran 5
LB - Libano 5
PA - Panama 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BH - Bahrain 4
EG - Egitto 4
LT - Lituania 4
OM - Oman 4
HR - Croazia 3
IL - Israele 3
PE - Perù 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SO - Somalia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
Totale 30.810
Salva come PNG Salva come JPEG
Città #
Fairfield 2.107
Woodbridge 1.882
Houston 1.681
Ann Arbor 1.318
Ashburn 1.118
Dallas 1.107
Wilmington 1.055
Chandler 897
Seattle 840
Dong Ket 774
Cambridge 694
San Jose 553
Dearborn 535
Singapore 449
Nyköping 441
Jacksonville 428
Shenzhen 397
Southend 392
Moscow 381
Beijing 332
Boardman 284
Lawrence 152
Princeton 152
The Dalles 127
Hong Kong 120
Ho Chi Minh City 114
Ogden 108
Shanghai 108
New York 102
Naples 98
Hanoi 74
San Diego 74
Santa Clara 72
Los Angeles 70
Grafing 69
Norwalk 63
Düsseldorf 62
London 54
Des Moines 52
Rome 51
Groningen 49
Chicago 46
São Paulo 45
Yubileyny 44
Munich 43
Falls Church 39
Nanjing 36
Kraków 34
Jinan 31
Dublin 29
Columbus 28
Tokyo 27
Rio de Janeiro 25
Milan 24
Bergamo 22
Shenyang 22
Helsinki 21
Hefei 19
Nanchang 19
Napoli 19
Brussels 18
Frankfurt am Main 18
Toledo 18
Amsterdam 17
Edinburgh 17
Mexico City 17
Auburn Hills 15
Baghdad 15
Council Bluffs 15
Guayaquil 15
Redwood City 15
Riga 15
Warsaw 15
Boston 14
Brasília 14
Bremen 14
Haiphong 14
Kunming 14
Washington 14
Belo Horizonte 13
Changsha 13
Curitiba 13
Da Nang 13
Montreal 13
Salt Lake City 13
Kilburn 12
Vienna 12
Baku 11
Florence 11
Guangzhou 11
Johannesburg 11
Lahore 11
Miami 11
Orem 11
Stockholm 11
Hangzhou 10
Lauterbourg 10
Nairobi 10
New Bedfont 10
Tashkent 10
Totale 20.543
Salva come PNG Salva come JPEG
Nome #
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy 634
Reliability and validity of Italian version of the Dimensional Apathy Scale in Parkinson’s Disease 337
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 322
Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study 320
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. 315
Apathy and related Executive Syndromes in Dementia associated with Parkinson’s Disease and in Alzheimer’s Disease 297
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale 288
Hearing Impairment in Parkinson’s Disease: Expanding the Non-Motor Phenotype 285
Abnormal eating behaviors in progressive supranuclear palsy 281
Cognitive and affective theory of mind in patients with essential tremor 278
Apathy in Parkinson’s Disease: diagnosis, neuropsychological correlates, pathophysiology and treatment 270
Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients 265
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 260
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 255
Affective theory of mind in patients with Parkinson's disease: comment 254
Impact of cognitive tasks on kinematic gait parameters in FTD patients 253
Effects of physical rehabilitation on gait pattern in parkinsonian patients with lateral trunk flexion: a three dimensional motion analysis investigation 253
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 253
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 251
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations 251
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients 251
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 251
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients 248
Apoptotic mechanisms in mutant LRRK2-mediated cell death 244
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions 242
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 237
Parkinson’s patients with or without MCI classified according to wavelet analysis of lower limb joint angles in gait cycle 236
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia 235
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease 235
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 235
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 232
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 230
Pathological gambling in Parkinson's disease. A comprehensive review 229
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease 229
Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients 227
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 225
The "eye of the tiger" sign in pure akinesia with gait freezing 223
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease 222
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 222
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients 219
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients 219
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 219
The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease 219
Gender and non motor fluctuations in Parkinson's disease: A prospective study 219
Gender and non motor fluctuations in Parkinson's disease: a prospective study 219
Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment 218
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. 218
How does smoking affect olfaction in Parkinson's disease? 217
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 216
Electrophysiological comparison between males and females in HNPP 214
Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait 212
Season of birth and Parkinson's disease: possible relationship? 211
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 209
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy 209
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 208
Cervico-oculo-Acoustic syndrome in a male with consanguineous parents 208
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages 208
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 207
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 206
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 205
Teaching NeuroImages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 205
Early MRI findings in Acquired hepatocerebral degeneration 204
A (single case) rehabilitation program based on cueing for freezing of speech 204
Normative data for the Montreal Cognitive Assessment in an Italian population sample 204
Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? 202
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 201
Uric acid relates to dopamine transporter availability in Parkinson's disease 201
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2 200
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. 199
Cognitive dysfunctions in occipital lobe epilepsy compared to temporal lobe epilepsy. 199
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 198
Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. 198
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease 198
Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease 197
The closing-in phenomenon in Parkinson's disease 197
Neuropsychological profile of adult patients with non symptomatic occipital lobe epilepsies 196
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 196
Comment on Poletti et al. “Affective theory of mind in patients with Parkinson's disease”. 195
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 192
Linkage exclusion in Italian families with hereditary essential tremor 192
Impulse Control Disorders induced by Rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 Cases 192
Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson’s Disease 190
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 190
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 189
Hemi-Restless Legs Syndrome induced by Clebopride 188
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 188
The relationship between cerebral vascular disease and parkinsonism: the VADO study 188
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 186
Link between non-motor symptoms and cognitive dysfunctions in de-novo, drug naïve PD patients 183
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients 182
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease 182
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease 181
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study 181
Using gait analysis' parameters to classify Parkinsonism: A data mining approach 181
The role of Vitamin D levels on neuropsychological profile of patients with Parkinson’s Disease 180
Reply to Zappia et al.'s comment on personality and Parkinson's Disease: A meta-analysis 178
Hearing impairment in Parkinson’s disease: expanding non motor phenotype 176
Quitting smoking: an early non-motor feature of Parkinson's disease? 176
Mild Cognitive Impairment in drug-naïve PD patients is associated with cerebral hypometabolism 176
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 176
Totale 22.496
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.386
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.528 189 151 44 402 84 102 163 120 98 95 50 30
2022/20232.611 310 164 143 315 236 436 106 312 312 75 150 52
2023/20241.229 91 44 449 46 26 106 32 81 171 61 18 104
2024/20254.479 61 360 26 109 96 401 1.121 1.358 336 238 206 167
2025/20265.459 377 863 793 480 224 112 540 524 623 577 186 160
2026/202766 66 0 0 0 0 0 0 0 0 0 0 0
Totale 31.130